Gregory Fraser
Stock Analyst at Truist Securities
(2.60)
# 2,269
Out of 4,981 analysts
38
Total ratings
53.57%
Success rate
14.95%
Average return
Main Sectors:
Stocks Rated by Gregory Fraser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $200 → $205 | $126.16 | +62.49% | 2 | Aug 28, 2025 | |
| ANIP ANI Pharmaceuticals | Maintains: Hold | $65 → $77 | $97.95 | -21.39% | 10 | Aug 11, 2025 | |
| BHC Bausch Health Companies | Maintains: Hold | $8 → $7 | $7.26 | -3.58% | 2 | Jul 25, 2024 | |
| XAIR Beyond Air | Maintains: Buy | $200 → $160 | $2.43 | +6,484.36% | 6 | Apr 30, 2024 | |
| BTMD biote | Maintains: Buy | $10 → $9 | $3.37 | +167.06% | 2 | Jan 18, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6 → $7 | $9.99 | -29.93% | 4 | Nov 8, 2023 | |
| CORT Corcept Therapeutics | Maintains: Hold | $26 → $29 | $72.87 | -60.20% | 5 | Aug 3, 2023 | |
| NVCR NovoCure | Reiterates: Buy | $95 | $12.15 | +681.89% | 3 | Jun 6, 2023 | |
| EOLS Evolus | Maintains: Buy | $14 → $18 | $7.20 | +150.17% | 2 | May 26, 2023 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $45 → $40 | $17.29 | +131.35% | 2 | May 26, 2023 |
Jazz Pharmaceuticals
Aug 28, 2025
Maintains: Buy
Price Target: $200 → $205
Current: $126.16
Upside: +62.49%
ANI Pharmaceuticals
Aug 11, 2025
Maintains: Hold
Price Target: $65 → $77
Current: $97.95
Upside: -21.39%
Bausch Health Companies
Jul 25, 2024
Maintains: Hold
Price Target: $8 → $7
Current: $7.26
Upside: -3.58%
Beyond Air
Apr 30, 2024
Maintains: Buy
Price Target: $200 → $160
Current: $2.43
Upside: +6,484.36%
biote
Jan 18, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $3.37
Upside: +167.06%
Amneal Pharmaceuticals
Nov 8, 2023
Maintains: Buy
Price Target: $6 → $7
Current: $9.99
Upside: -29.93%
Corcept Therapeutics
Aug 3, 2023
Maintains: Hold
Price Target: $26 → $29
Current: $72.87
Upside: -60.20%
NovoCure
Jun 6, 2023
Reiterates: Buy
Price Target: $95
Current: $12.15
Upside: +681.89%
Evolus
May 26, 2023
Maintains: Buy
Price Target: $14 → $18
Current: $7.20
Upside: +150.17%
Arcutis Biotherapeutics
May 26, 2023
Maintains: Buy
Price Target: $45 → $40
Current: $17.29
Upside: +131.35%